Pele has signed up with Pfizer to continue his work on raising awareness of erectile dysfunction for the pharma company.The …
GlaxoSmithKline’s head of international pharmaceutical operations, Howard Pien, is to leave the company to become Chief Executive of Chiron.Mr Pien’s …
GlaxoSmithKline leads the industry in licensing in new drugs, buying the rights to nearly twice as many products as its …
The pharmaceutical industry's negative view of PR has persuaded healthcare agency Jo Spink Public Relations to re-brand itself as Spink …
Abbott Labs' human monoclonal antibody Humira has received a positive opinion from the EMEA for the treatment of rheumatoid arthritis, …
Pfizer's follow up to its multi-billion dollar painkiller Celebrex has been approved for marketing across the European Union following a …
Mental health charity MIND has criticised the way the Medicines Control Agency handles drug regulation, saying it is "playing Russian …
Mental health and primary care trusts could eventually take on foundation status, according to Health Secretary Alan Milburn.He said he …
Allied Health Professionals are to be encouraged to play a greater role in prescribing as part of a new government …
Omeprazole, the blockbuster ulcer drug discovered by AstraZeneca, could soon be dispensed by pharmacists without a prescription, pending final approval …
Eli Lilly has been publicly reprimanded for bringing the pharmaceutical industry into disrepute after promoting its erectile dysfunction treatment Cialis …
A ruling by the US Supreme Court could clear the way for US states to enforce hugely increased prescription price …
GlaxoSmithKline and Bayer's erectile dysfunction is to become Viagra's first major competitor in the US after receiving marketing approval.Launched in …
Schering-Plough's new chief executive and chairman Fred Hassan, has forgone a bonus of up to $2 million bonus to demonstrate …
Pharmaceutical companies should be allowed to set their own prices in all the European Union countries in order to bring …